| GNB2L1 |
Lung cancer oncogene 7 |
GRIN2A |
GRIN2A, NMDAR2A: Glutamate [NMDA] receptor subunit epsilon-1 precursor |
2.135 |
Evidence |
|
| ATM |
ATM: Serine-protein kinase ATM |
RAPGEF6 |
RAPGEF6, PDZGEF2: Rap guanine nucleotide exchange factor 6 |
2.135 |
Evidence |
|
| RAP1B |
RAP1B, OK/SW-cl.11: Ras-related protein Rap-1b precursor |
STK38 |
STK38, NDR1: Serine/threonine-protein kinase 38 |
2.135 |
Evidence |
|
| WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
ARHGDIB |
ARHGDIB, GDIA2, GDID4, RAP1GN1: Rho GDP-dissociation inhibitor 2 |
2.135 |
Evidence |
|
| RPL3 |
RPL3, OK/SW-cl.32: 60S ribosomal protein L3 |
RPS10 |
RPS10: 40S ribosomal protein S10 |
2.135 |
Evidence |
|
| DDX5 |
DDX5, G17P1, HELR, HLR1: Probable ATP-dependent RNA helicase DDX5 |
SFRS5 |
SFRS5, HRS, SRP40: Splicing factor, arginine/serine-rich 5 |
2.135 |
Evidence |
|
| HCLS1 |
HCLS1, HS1: Hematopoietic lineage cell-specific protein |
DOCK2 |
DOCK2, KIAA0209: Dedicator of cytokinesis protein 2 |
2.135 |
Evidence |
|
| KIAA0788 |
ASCC3L1, HELIC2, KIAA0788: U5 small nuclear ribonucleoprotein 200 kDa helicase |
HDAC1 |
HDAC1, RPD3L1: Histone deacetylase 1 |
2.135 |
Evidence |
|
| KIAA0788 |
ASCC3L1, HELIC2, KIAA0788: U5 small nuclear ribonucleoprotein 200 kDa helicase |
SFRS2 |
SFRS2: Splicing factor, arginine/serine-rich 2 |
2.135 |
Evidence |
|
| SF3B1 |
SF3B1, SAP155: Splicing factor 3B subunit 1 |
SFRS5 |
SFRS5, HRS, SRP40: Splicing factor, arginine/serine-rich 5 |
2.135 |
Evidence |
|
| WASPIP |
IPI00552369 |
STK10 |
STK10: Uncharacterized protein STK10 |
2.135 |
Evidence |
|
| RBBP4 |
RBBP4, RBAP48: Histone-binding protein RBBP4 |
FKBP5 |
FKBP5, AIG6, FKBP51: FK506-binding protein 5 |
2.132 |
Evidence |
|
| PTK6 |
PTK6, BRK: Tyrosine-protein kinase 6 |
CBLC |
CBLC, CBL3, RNF57: Signal transduction protein CBL-C |
2.132 |
Evidence |
|
| IRAK1 |
IRAK1, IRAK: Interleukin-1 receptor-associated kinase 1 |
FADD |
FADD, MORT1: Protein FADD |
2.132 |
Evidence |
|
| RPS10 |
RPS10: 40S ribosomal protein S10 |
FADD |
FADD, MORT1: Protein FADD |
2.132 |
Evidence |
|
| CXCL5 |
CXCL5, ENA78, SCYB5: Small-inducible cytokine B5 precursor |
F2RL1 |
F2RL1, GPR11, PAR2: Proteinase-activated receptor 2 precursor |
2.132 |
Evidence |
|
| DSG3 |
DSG3: Desmoglein-3 precursor |
PKP3 |
PKP3: Plakophilin-3 |
2.132 |
Evidence |
|
| GNAO1 |
GNAO1: Guanine nucleotide-binding protein G(o) subunit alpha 2 |
RGS4 |
RGS4: Regulator of G-protein signaling 4 |
2.132 |
Evidence |
|
| EPHA2 |
EPHA2, ECK: Ephrin type-A receptor 2 precursor |
PTK6 |
PTK6, BRK: Tyrosine-protein kinase 6 |
2.132 |
Evidence |
|
| CCL1 |
CCL1, SCYA1: Small-inducible cytokine A1 precursor |
P2RY4 |
P2RY4, NRU: P2Y purinoceptor 4 |
2.132 |
Evidence |
|
| ICAM2 |
ICAM2: Intercellular adhesion molecule 2 precursor |
MSN |
MSN: Moesin |
2.132 |
Evidence |
O
|
| CCL5 |
CCL5, D17S136E, SCYA5: Small-inducible cytokine A5 precursor |
CCR5 |
CCR5: CCR5 receptor (Fragment) |
2.132 |
Evidence |
O
|
| CCL2 |
CCL2, MCP1, SCYA2: Small-inducible cytokine A2 precursor |
F2RL1 |
F2RL1, GPR11, PAR2: Proteinase-activated receptor 2 precursor |
2.132 |
Evidence |
|
| PF4V1 |
PF4V1, SCYB4V1: Platelet factor 4 variant precursor |
FPRL1 |
FPRL1, FPR2, FPRH1, LXA4R: FMLP-related receptor I |
2.132 |
Evidence |
|
| GNAI3 |
GNAI3: Guanine nucleotide-binding protein G(k) subunit alpha |
RGS19 |
RGS19, GAIP, GNAI3IP: Regulator of G-protein signaling 19 |
2.132 |
Evidence |
O
|